By registering, you will be signed-up for an account which gives you access to a free story published once a week and archives of all our free stories. You will also receive a daily newsletter sent to your inbox. To unsubscribe, please visit the profile section in your account.

Account successfully created

Logging you in...

Almost done. A confirmation email has been sent to 'Email Address'. Click on the link in the email to activate your account.

After dropping the "unimplementable" 2017 national rare diseases policy in December last year, and in the face of multiple court cases, India's health ministry has promised a new policy in nine months. But will it be enough for millions with spinal muscular atrophy, brittle bone disease and more?

23/02/19

Pranav Srivilasan

"Rare diseases" affect only a tiny slice of the population—but in a country of India's scale, they add up to anywhere between 70 million and 100 million people

Most of these diseases have no cure or treatment, and all too often, it just doesn't make sense for pharma companies to invest in them

But thanks to favourable laws and incentives in places like the US and Europe, global sales of "orphan" drugs have risen far faster than their regular counterparts

Can India—where affordability and access are both huge issues—come up with its own solution to the intrinsic demand-supply problem of rare diseases?

“I have broken bones while sleeping.” P* is 34. She lives in Borivali, a suburb of Mumbai, the city where she was born and raised. She works at an office in one of the city’s commercial hubs and spends hours on the infamous local trains every day. Much like most people in the city. But…

By registering, you will be signed-up for an account which gives you access to a free story published once a week and archives of all our free stories. You will also receive a daily newsletter sent to your inbox. To unsubscribe, please visit the profile section in your account.

Daily Newsletters

The Ken is a subscription-driven media site. We write one story a day (weekdays only). These stories have sharp, original insights on technology, business, science and healthcare from India.

Why do I have to sign up to read your stories?

Our stories are not free. Well, some select stories are. But, a significant part of what we write at The Ken is for subscribers only. We put in a lot of effort and resources in writing our stories and believe that you must pay for good journalism. Hence, our three plans.
1) The annual membership
2) The free sign up
3) The recurring quarterly subscription

On journalism and why you should pay for it, if you haven’t already seen it, here’s a great explainer from John Oliver.

So, one must pay for journalism?

Yes.

How many stories will I get if I take an annual membership?

804+ stories.

And, in the free sign up?

Four stories every month.

Do I get a refund?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am not getting my daily emails. Do I have to whitelist emails from The Ken?

An added benefit of your subscription (free/paid) are the daily personalised emails. These emails, at times, might end up in your spam/junk folder due to emojis, attachments or images. In case you’re not receiving these emails, it might help to whitelist us. If the problem still persists, write to us at [email protected].

Why am I unable to access the archives?

Full and unrestricted access to our archives is a feature of our annual membership.

“I have broken bones while sleeping.” P* is 34. She lives in Borivali, a suburb of Mumbai, the city where she was born and raised. She works at an office in one of the city’s commercial hubs and spends hours on the infamous local trains every day. Much like most people in the city. But…

Dear subscriber - a lot of hard work goes into the journalism we put out. While sharing snippets or limited screenshots is okay, please avoid printing and sharing our entire articles as PDFs. Our plans are very affordable - please ask your friends to subscribe.

"An article from The Ken has become an intrinsic part of my daily news diet."

Nandan Nilekani, Former Chairman, UIDAI

Welcome to The Ken

As a part of the Learning and Development program at Myntra-Jabong, you have complete access to 300+ original daily stories over the next year, 500+ previously published stories and our comment sections. Also, do keep an eye out for our exclusive subscriber-only iOS and Android apps which will be rolled out for you shortly.

Happy Reading!

By continuing to browse our site you agree to our use of cookies to improve our performance and enhance your user experience.